Alopecia areata. Alopecia areata
Conditions
Interventions
Intervention 1: Intervention group: The first Group was Treated with 2% Tofacitinib Niosomal Lotion. Intervention 2: Intervention group: The second Group was Treated with 0.01% Clobetasol Lotion.
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to No maximum
Inclusion criteria
Inclusion criteria: Age Equal to or Greater Than Four Years Alopecia Areata Patchy Form (SALT = 25%) Not Using Other Hair Loss Treatments in the Past Three Months Ability and Willingness to Follow Instructions for Using Lotions Normal Tests Include: CBC, Creatinine, Liver Tests, Thyroid Tests, Anti-Thyroperoxidase and Thyroglobulin Antibodies, and FBS
Exclusion criteria
Exclusion criteria: History of Autoimmune Diseases and Use of Biological Therapies and Immunosuppressants Within the Past 6 Months Use of Topical Corticosteroids in the Past Month at the Site Pregnancy, Breastfeeding Phototherapy within the past 3 Months Thyroid Dysfunction Cytopenia (Leukocytes > 3 × 10^9, Lymphocytes > 0.8 × 10^9, Neutrophils < Lower Limit of Normal Range, Hemoglobin < 10 g/dl, Platelets < 100 × 10^9)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair Loss Treatment. Timepoint: 12 Weeks. Method of measurement: Measuring the Percentage of Hair Loss with SALT Score, Regrowth Rate. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBanafshe Farzadfard
Kerman University of Medical Sciences
Outcome results
None listed